CNBC: Pfizer Says Its COVID Vaccine for Kids Under 5 Has Met the Goals of Its Clinical Trial

KERNEN Breaking news from ░░░░░░░░ Meg Tirrell joins us ░░░░░░░░ with that news and ░░░░░░░░ Hi Meg TIRRELL Hey ░░░░░░░░ Pfizer saying that its ░░░░░░░░ for kids under 5 ░░░░░░░░ met the goals of ░░░░░░░░ clinical trial in terms ░░░░░░░░ the immune response and ░░░░░░░░ and that they plan ░░░░░░░░ file this now three ░░░░░░░░ vaccine with the FDA ░░░░░░░░ week They also have ░░░░░░░░ preliminary efficacy data in ░░░░░░░░ They say 80 percent ░░░░░░░░ was provided by three ░░░░░░░░ against symptomatic Covid in ░░░░░░░░ period when Omicron was ░░░░░░░░ predominantly circulating variant The ░░░░░░░░ profile they said was ░░░░░░░░ to the placebo In ░░░░░░░░ of that 80 percent ░░░░░░░░ that s preliminary based ░░░░░░░░ about 10 cases that ░░░░░░░░ saw on the trial ░░░░░░░░ need 21 to really ░░░░░░░░ it final so that ░░░░░░░░ get updated But based ░░░░░░░░ this bringing this to ░░░░░░░░ FDA I remember guys ░░░░░░░░ had been delayed They ░░░░░░░░ filing with just two ░░░░░░░░ back in February decided ░░░░░░░░ efficacy wasn t strong ░░░░░░░░ in this age of ░░░░░░░░ went back and added ░░░░░░░░ third dose This is ░░░░░░░░ very low dose You ░░░░░░░░ see the comparison here ░░░░░░░░ Pfizer and Moderna Moderna ░░░░░░░░ course already under review ░░░░░░░░ the FDA with two ░░░░░░░░ at 25 micrograms Pfizer ░░░░░░░░ now three doses at ░░░░░░░░ three micrograms These are ░░░░░░░░ expected to go through ░░░░░░░░ FDA process and potentially ░░░░░░░░ to advisory committee meetings ░░░░░░░░ June A lot of ░░░░░░░░ guys who ve been ░░░░░░░░ a long time for ░░░░░░░░ Still no vaccine available ░░░░░░░░ kids under 5. Joe?”